Advisor 462
First page
Table of contents
Next page
Last page
Frequency of MHRA GPvP inspection findings unchanged
3
EC issues guidance to mitigate EU clinical trial disruption during the pandemic
4
New European pharmacovigilance inspection follow-up procedures
5
EMA addresses validation and qualification of computerised systems used in trials
6
Korean device company’s CAPA procedures and responses fail to impress the FDA
8
STOP PRESS - global news
2
EMA starts rolling review of a potential COVID-19 treatment
2
German guidance on clinical trials during the pandemic
2
Changing face of FDA drug approvals
2
Communicating results of COVID-19 trials
2
New FDA guidance on non-binding feedback after device inspections
2
Made with
FlippingBook
- professional solution for displaying marketing and sales documents online